These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 8200946)

  • 41. Differing thresholds for modulatory effects of adrenomedullin infusion on haemodynamic and hormone responses to angiotensin II and adrenocorticotrophic hormone in healthy volunteers.
    Troughton RW; Frampton CM; Lewis LK; Yandle TG; Richards AM; Nicholls MG
    Clin Sci (Lond); 2001 Jul; 101(1):103-9. PubMed ID: 11410122
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vascular effects of natriuretic peptides in healthy men.
    Komarek M; Bernheim A; Schindler R; Steden R; Kiowski W; Brunner-La Rocca HP
    J Cardiovasc Pharmacol Ther; 2004 Dec; 9(4):263-70. PubMed ID: 15678245
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hormonal responses to synthetic atrial natriuretic peptide in patients on regular hemodialysis.
    Nakajima S; Suzuki H; Kageyama Y; Takita T; Saruta T
    Acta Endocrinol (Copenh); 1988 Oct; 119(2):257-62. PubMed ID: 2972150
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clearance receptors and endopeptidase: equal role in natriuretic peptide metabolism in heart failure.
    Rademaker MT; Charles CJ; Kosoglou T; Protter AA; Espiner EA; Nicholls MG; Richards AM
    Am J Physiol; 1997 Nov; 273(5):H2372-9. PubMed ID: 9374774
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of high dose atrial natriuretic peptide on renal haemodynamics, sodium handling and hormones in cirrhotic patients with and without ascites.
    Jespersen B; Eiskjaer H; Jensen JD; Mogensen CE; Sørensen SS; Pedersen EB
    Scand J Clin Lab Invest; 1995 Jul; 55(4):273-87. PubMed ID: 7569729
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hemodynamic, hormone, and urinary effects of adrenomedullin infusion in essential hypertension.
    Troughton RW; Lewis LK; Yandle TG; Richards AM; Nicholls MG
    Hypertension; 2000 Oct; 36(4):588-93. PubMed ID: 11040240
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of physiological increments in human alpha-atrial natriuretic peptide and human brain natriuretic peptide in normal male subjects.
    Cheung BM; Dickerson JE; Ashby MJ; Brown MJ; Brown J
    Clin Sci (Lond); 1994 Jun; 86(6):723-30. PubMed ID: 8062508
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Low dose infusions of 26- and 28-amino acid human atrial natriuretic peptides in normal man.
    Richards AM; Tonolo G; Montorsi P; Finlayson J; Fraser R; Inglis G; Towrie A; Morton JJ
    J Clin Endocrinol Metab; 1988 Mar; 66(3):465-72. PubMed ID: 2965159
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Atrial natriuretic peptide and C-type natriuretic peptide in spontaneously hypertensive rats and their vasorelaxing actions in vitro.
    Wei CM; Kim CH; Khraibi AA; Miller VM; Burnett JC
    Hypertension; 1994 Jun; 23(6 Pt 2):903-7. PubMed ID: 8206626
    [TBL] [Abstract][Full Text] [Related]  

  • 50. C-type natriuretic peptide mediates the hypothalamic actions of the natriuretic peptides to inhibit luteinizing hormone secretion.
    Samson WK; Huang FL; Fulton RJ
    Endocrinology; 1993 Feb; 132(2):504-9. PubMed ID: 8425472
    [TBL] [Abstract][Full Text] [Related]  

  • 51. C-type natriuretic peptide stimulates catecholamine synthesis through the accumulation of cyclic GMP in cultured bovine adrenal medullary cells.
    Tsutsui M; Yanagihara N; Minami K; Kobayashi H; Nakashima Y; Kuroiwa A; Izumi F
    J Pharmacol Exp Ther; 1994 Feb; 268(2):584-9. PubMed ID: 7906732
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of frusemide on atrial natriuretic peptide, guanosine cyclic monophosphate, angiotensin II, aldosterone, vasopressin, prostaglandin E2 and blood volume in the nephrotic syndrome.
    Jespersen B; Sørensen SS; Pedersen EB
    Nephrol Dial Transplant; 1991; 6(6):402-9. PubMed ID: 1652115
    [TBL] [Abstract][Full Text] [Related]  

  • 53. C-type natriuretic peptide increases myocardial contractility and sinus rate mediated by guanylyl cyclase-linked natriuretic peptide receptors in isolated, blood-perfused dog heart preparations.
    Hirose M; Furukawa Y; Kurogouchi F; Nakajima K; Miyashita Y; Chiba S
    J Pharmacol Exp Ther; 1998 Jul; 286(1):70-6. PubMed ID: 9655843
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Natriuretic peptide system and endothelin in aneurysmal subarachnoid hemorrhage.
    Wijdicks EF; Schievink WI; Burnett JC
    J Neurosurg; 1997 Aug; 87(2):275-80. PubMed ID: 9254093
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of low dose infusions of ile-atrial natriuretic peptide in healthy elderly males: evidence for a postreceptor defect.
    Or K; Richards AM; Espiner EA; Yandle T; Gilchrist N; Sainsbury R
    J Clin Endocrinol Metab; 1993 May; 76(5):1271-4. PubMed ID: 8388403
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Urinary endothelin-1 excretion is enhanced by low-dose infusion of brain natriuretic peptide in normal humans.
    De Feo ML; La Villa G; Lazzeri C; Tosti-Guerra C; Becorpi A; Pupilli C; Mannelli M
    Hypertension; 1997 Jan; 29(1 Pt 1):70-4. PubMed ID: 9039083
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The neuro-cardio-endocrine response to acute subarachnoid haemorrhage.
    Espiner EA; Leikis R; Ferch RD; MacFarlane MR; Bonkowski JA; Frampton CM; Richards AM
    Clin Endocrinol (Oxf); 2002 May; 56(5):629-35. PubMed ID: 12030914
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of atrial natriuretic factor in changes in the responsiveness of aldosterone to angiotensin II secondary to sodium loading and depletion in man.
    Tuchelt H; Eschenhagen G; Bähr V; Schwietzer G; Thiede HM; Oelkers W
    Clin Sci (Lond); 1990 Jul; 79(1):57-65. PubMed ID: 2167792
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Atrial natriuretic peptide and blood volume in patients with chronic glomerulonephritis: effects of albumin and frusemide administration.
    Jespersen B; Danielsen H; Pedersen EB
    Nephrol Dial Transplant; 1990; 5(12):997-1006. PubMed ID: 1965738
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vasodilatory effects of C-type natriuretic peptide on forearm resistance vessels are distinct from those of atrial natriuretic peptide in chronic heart failure.
    Nakamura M; Arakawa N; Yoshida H; Makita S; Hiramori K
    Circulation; 1994 Sep; 90(3):1210-4. PubMed ID: 8087930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.